Silicon Valley Capital Partners’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
Silicon Valley Capital Partners's PFE Position: Q1 2026 in Review
Silicon Valley Capital Partners increased its Pfizer (PFE) stake by 0.48% in Q1 2026, buying an estimated $932 and bringing the position to 7,397 shares worth $208K. The position accounts for 0.02% of the portfolio, ranked #99.
Silicon Valley Capital Partners first reported a position in PFE in Q4 2020 and has held it in 17 quarters since. The position peaked at $421K in Q3 2024. 2,938 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Silicon Valley Capital Partners held 7,397 shares of Pfizer worth $208K as of Q1 2026.
- Silicon Valley Capital Partners bought 35 Pfizer shares in Q1 2026, an estimated $932.
- Pfizer made up 0.02% of Silicon Valley Capital Partners's portfolio in Q1 2026, its #99 holding.
- Silicon Valley Capital Partners first reported a position in Pfizer in Q4 2020 and has held it in 17 quarters since.
- Silicon Valley Capital Partners's Pfizer position peaked at $421K in Q3 2024.
- 2,938 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Silicon Valley Capital Partners's 13F filing for Q1 2026, filed 19 May 2026.